United States v. Major

801 F. Supp. 2d 511, 2011 U.S. Dist. LEXIS 84875, 2011 WL 3320800
CourtDistrict Court, E.D. Virginia
DecidedAugust 1, 2011
DocketCriminal 1:11cr16
StatusPublished
Cited by1 cases

This text of 801 F. Supp. 2d 511 (United States v. Major) is published on Counsel Stack Legal Research, covering District Court, E.D. Virginia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Major, 801 F. Supp. 2d 511, 2011 U.S. Dist. LEXIS 84875, 2011 WL 3320800 (E.D. Va. 2011).

Opinion

MEMORANDUM OPINION

T.S. ELLIS, III, District Judge.

In this criminal prosecution, defendant pled guilty pursuant to a written plea agreement to one count of conspiracy to distribute N-Benzylpiperazine (BZP), in violation of 21 U.S.C. §§ 841 and 846, and one count of possession of a firearm and ammunition by a convicted felon, in violation of 18 U.S.C. §§ 922(g)(1) and 924(e)(1). The subsequent sentencing proceedings presented two significant issues requiring resolution, namely (i) the appropriate guidelines analysis for a drug offense involving BZP, a Schedule I controlled substance that is not specifically referenced in the guidelines, and (ii) whether defendant’s three prior convictions for statutory burglary under Virginia law constituted predicate “violent felonies]” under the Armed Career Criminal Act (ACCA), 18 U.S.C. § 924(e)(1), thus mandating a minimum fifteen-year custody sentence in this case. Following extensive briefing and oral argument, defendant was ultimately sentenced to concurrent sentences of three years on the drug conspiracy charge and fifteen years on the firearm charge, the mandatory minimum required under the ACCA. Recorded here are the reasons underlying the BZP and ACCA rulings made in the course of the sentencing proceedings.

*513 I.

The starting point in the BZP analysis is, of course, the language of the guidelines themselves. In this regard, it is undisputed that BZP is a controlled substance that “is not specifically referenced” in the guidelines. U.S.S.G. § 2D1.1 cmt. n. 5. In that circumstance, the guidelines direct sentencing courts to “determine the base offense level using the marihuana equivalency of the most closely related controlled substance referenced” in the guidelines. Id. And, in determining the most closely related controlled substance, sentencing courts are advised to consider the following factors:

(A) Whether the controlled substance not referenced in this guideline has a chemical structure that is substantially similar to a controlled substance referenced in this guideline.
(B) Whether the controlled substance not referenced in this guideline has a stimulant, depressant, or hallucinogenic effect on the central nervous system that is substantially similar to the stimulant, depressant, or hallucinogenic effect on the central nervous system of a controlled substance referenced in this guideline.
(C) Whether a lesser or greater quantity of the controlled substance not referenced in this guideline is needed to produce a substantially similar effect on the central nervous system as a controlled substance referenced in this guideline.

Id.

Despite the fact that BZP has been, and continues to be involved in criminal prosecutions across the country, it appears the Sentencing Commission has not yet advocated a formal position concerning “the most closely related controlled substance” to BZP for purposes of the guidelines analysis. This being the ease, sentencing courts must rely on published literature and chemical studies conducted by other external sources, such as the Drug Enforcement Administration (DEA). In this regard, the DEA’s website expressly states that “the pharmacological effects of BZP are qualitatively similar to those of amphetamine.” NBenzylpiperazine (Street Names: BZP, A2, Legal E or Legal X). http://www.deadiversion.usdoj.gov/drugs_concern/bzp_tmp/bzp_tmp.htm (last visited July 26.2011) (emphasis added). 1

The DEA’s conclusion that BZP is “most closely related” to amphetamine for purposes of the guidelines analysis is consistent with recent judicial decisions from other circuits. See, e.g., United States v. Rose, 722 F.Supp.2d 1286, 1289 (M.D.Ala.2010) (stating that “[o]n its own, BZP is like amphetamine in that it is a central-nervous-system stimulant, although it is ten to 20 times less potent”). Other courts have also sensibly recognized that the fact *514 that BZP is significantly less potent than amphetamine is an issue to be considered, not in determining the applicable base offense level under the guidelines, but instead in determining whether a variance from the advisory guidelines range is warranted in light of the factors set forth in 18 U.S.C. § 3553(a). See id. at 1291 (recognizing that defendant was entitled to a variance under § 3553(a), in part “[b]e-cause the diminished potency of BZP ... was not accounted for in calculating [defendant’s] offense level”).

In this case, using amphetamine as the most closely related drug to BZP results in a guidelines base offense level of 18 for defendant’s drug conspiracy offense. Specifically, where, as here, the weight of the controlled substance is unknown, sentencing courts are directed to “multiply the number of doses, pills, or capsules by the typical weight per dose ... to estimate the total weight of the controlled substance.” U.S.S.G. § 2D1.1 cmt. n. 11. Here, the record reflects — and defendant admitted in his sworn statements of facts — that he is accountable for a total of 1.000 pills containing a detectable amount of BZP. See United States v. Major, 1:11cr16 (E.D.Va. Mar. 4, 2011) (Statement of Facts, ¶ 15) (providing that “the defendant was personally involved in the distribution of, and it was reasonably foreseeable to the defendant that the co-conspirators distributed 1,000 pills containing a delectable amount of N-Benzylpiperazine”). This quantity of pills, multiplied by the typical weight per dose of amphetamine results in an estimated weight of 10 grams of amphetamine. See U.S.S.G. § 2D1.1 cmt. n. 11 (providing that the typical weight per dose of amphetamine is 10 milligrams). Ten grams of amphetamine, in turn, equates to 20 kilograms of marijuana under the guidelines’ equivalency table, resulting in a base offense level of 18 pursuant to U.S.S.G. § 2Dl.l(c) (providing a base offense level of 18 for “[a]t least 20 KG but less than 40 KG of Marihuana”). Two additional levels were then added to this base offense level pursuant to U.S.S.G. § 2D1.1(b)(1), based on defendant’s possession of a firearm, resulting in an adjusted offense level of 20 for the drug conspiracy charge.

As it happens, however, the BZP analysis and the resulting guidelines calculations were not ultimately determinative of defendant’s final guidelines range of imprisonment given the higher offense level applicable to the related firearm offense. In this regard, the base offense level applicable to defendant’s § 922(g) firearm offense was 20, pursuant to U.S.S.G. § 2K2.1(a)(4).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Major
198 F. Supp. 3d 558 (E.D. Virginia, 2016)

Cite This Page — Counsel Stack

Bluebook (online)
801 F. Supp. 2d 511, 2011 U.S. Dist. LEXIS 84875, 2011 WL 3320800, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-major-vaed-2011.